Diabetic Neuropathy
19 Oct 2020STZ-induced preclinical Diabetic neuropathy is our model of the month. Mechanical hyperalgesia and allodynia experienced by patients can be precisely mimicked and quantified.
Last call for ALGOGram™
06 Oct 2020Last call for the next available ALGOGram™ Fall session. Don’t miss it! √ A decision-making guide in developing the all-important product profile for your test compounds.
ISO 9001-2015 Certification
29 Sep 2020ANS Biotech has successfully renewed its ISO 9001-2015 certification. The company is ISO 9001 certified since 2014 and maintains every day the highest quality standards for its Customers’ satisfaction.
Preclinical Pruritus Model
18 Sep 20205-HT-induced preclinical Pruritus model is our model of the month! The spontaneous behavior of scraping the injected area mimics itch situation experienced by patients”
ALGOGram™ Fall session
16 Sep 2020The registration for the upcoming ALGOGram™ Fall session is now open! √ A decision-making guide in developing the all-important product profile for your test compounds.
ANS Biotech appoints Dr. Philippe Genne to board of directors
08 Sep 2020ANS Biotech is very happy and proud to welcome Dr. Philippe Genne, President and CEO of Oncodesign, as new member of the board of directors. Click here to access to the entire press release.
Register Now for ANS Biotech webinar, September 17th
27 Aug 2020"Pharmacology and mechanisms of Oxaliplatin-induced neuropathic pain" by our CSO, Laurent DIOP. During this webinar, we will discuss: Clinical syndrome and diagnosis Mechanisms of CIPN Pharmacology and treatment Attendance is free, but registration is required. REGISTER NOW
Spared Nerve Injury
18 Aug 2020Spared Nerve Injury (SNI)-induced peripheral neuropathy pain is our model of the month! SNI model of peripheral mononeuropathy.
ALGOGram™ Back to School
04 Aug 2020The registration for the upcoming ALGOGram™ “Back to school” ! A decision-making guide in developing the all-important product profile for your test compounds.
Bone Cancer Pain
21 Jul 2020MRMT-1 Tumor cells-induced BCP is our model of the month! Bone is a privileged site of metastases for large primary tumors.